Anti-Interleukin-6 Receptor Antibody Therapy-Induced Retinopathy in a Patient with Rheumatoid Arthritis

Anti-Interleukin-6 Receptor Antibody Therapy-Induced Retinopathy in a Patient with Rheumatoid Arthritis

Tocilizumab, a humanized anti-human interleukin-6 (IL-6) receptor monoclonal antibody, is beneficial for treating autoimmune conditions such as rheumatoid arthritis (RA). The most common adverse event is upper respiratory tract infection; ocular side effects are rare. We describe a case of skin ulce...

Full description

Bibliographic Details
Main Authors:	Asumi Tada, Noriyasu Hashida, Toshio Tanaka, Kohji Nishida
Format:	Article
Language:	English
Published:	Hindawi Limited 2012-01-01
Series:	Case Reports in Rheumatology
Online Access:	http://dx.doi.org/10.1155/2012/270315

Similar Items

Interleukin 6 and Rheumatoid Arthritis
by: Yuji Yoshida, et al.
Published: (2014-01-01)

Tocilizumab, a humanized anti-interleukin-6 receptor antibody, for treatment of rheumatoid arthritis
by: Masahiko Mihara, et al.
Published: (2011-02-01)

Serum Proteome Analysis in Patients with Rheumatoid Arthritis Receiving Therapy with Tocilizumab: An Anti-Interleukin-6 Receptor Antibody
by: Mitsuaki Yanagida, et al.
Published: (2013-01-01)

Effects of Tocilizumab, an Anti-Interleukin-6 Receptor Antibody, on Serum Lipid and Adipokine Levels in Patients with Rheumatoid Arthritis
by: Elinoar Hoffman, et al.
Published: (2019-09-01)

Interleukin-6 receptor in the recent-onset rheumatoid arthritis
by: Montes-Cano Marco, et al.
Published: (2011-11-01)

Interleukin-6 in Rheumatoid Arthritis
by: Franco Pandolfi, et al.
Published: (2020-07-01)

New approaches to pharmacotherapy for rheumatoid arthritis: perspective for use of tocilizumab (monoclonal antibodies to interleukin-6 receptor)
by: Evgeniy L'vovich Nasonov, et al.
Published: (2010-05-01)

Increase of hemoglobin levels by anti-IL-6 receptor antibody (tocilizumab) in rheumatoid arthritis.
by: Motomu Hashimoto, et al.
Published: (2014-01-01)

Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis
by: T. Robak, et al.
Published: (1998-01-01)

Possible Role of Interleukin-6 in Rheumatoid Arthritis
by: Batool A. Al-Haidary
Published: (2007-07-01)

Interleukin-6 inhibitors in the treatment of rheumatoid arthritis
by: Stephanie Hennigan, et al.
Published: (2008-09-01)

Interleukin-6 gene polymorphism and rheumatoid arthritis
by: Rujittika Mungmunpuntipantip, et al.
Published: (2020-01-01)

The efficacy and safety of sarilumab, fully human monoclonal antibodies against interleukin 6 receptor, in rheumatoid arthritis: new evidence
by: E. L. Nasonov, et al.
Published: (2019-11-01)

Resolution of the National Multidisciplinary Research Council of Experts on the place of anti-interleukin-6 receptor monoclonal antibodies (Sarilumab) in the treatment of patients with rheumatoid arthritis and comorbidity
by: article Editorial
Published: (2020-06-01)

Role of interleukin-6 in the development of atherosclerosis in rheumatoid arthritis
by: Elena Vasilyevna Udachkina, et al.
Published: (2013-10-01)

Primary pathologic role of interleukin-6 in rheumatoid arthritis
by: G.L. Bajocchi, et al.
Published: (2013-05-01)

Anti-chromatin antibodies in juvenile rheumatoid arthritis
by: F. Ingegnoli, et al.
Published: (2003-12-01)

Three Cases of Previous Smokers with Rheumatoid Arthritis Who Did Not Respond to Tumor Necrosis Factor Inhibitors Were Treated Successfully with an Anti-Interleukin-6 Receptor Antibody
by: Yasuo Iwata
Published: (2015-01-01)

B-lymphocyte subpopulations in patients with rheumatoid arthritis and the effect of an interleukin-6 receptor inhibitor on them.
by: E. V. Gerasimova, et al.
Published: (2019-01-01)

Interleukin-6 inhibition for treatment of rheumatoid arthritis: A review of tocilizumab therapy
by: Aarat M Patel, et al.
Published: (2010-10-01)

Interleukin-6 inhibition and cardiovascular disease in patients with rheumatoid arthritis
by: T V Popkova, et al.
Published: (2016-05-01)

Interleukin-6 blockade Improves Autonomic Dysfunction in Rheumatoid Arthritis
by: Ashit Syngle, et al.
Published: (2015-01-01)

Anti-Drug Antibodies, Drug Levels, Interleukin-6 and Soluble TNF Receptors in Rheumatoid Arthritis Patients during the First 6 Months of Treatment with Adalimumab or Infliximab: A Descriptive Cohort Study.
by: Grith Petersen Eng, et al.
Published: (2016-01-01)

Specificity of Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis
by: Nicole H. Trier, et al.
Published: (2019-06-01)

Rheumatoid Arthritis and Anti-Arg-Gingipain A Antibody
by: Shih-Hong Siao, et al.
Published: (2013)

Choroidal Nevus in an Eye with Polypoidal Choroidal Vasculopathy
by: Kazunobu Asao, et al.
Published: (2014-12-01)

Corneal infiltration and xanthoma formation in mycosis fungoides
by: Caleb Busch, et al.
Published: (2018-09-01)

Diagnostic Evaluation of Ocular Toxocariasis Using High-Penetration Optical Coherence Tomography
by: Noriyasu Hashida, et al.
Published: (2014-01-01)

Choroidal Excavation in Vogt-Koyanagi-Harada Disease
by: Noriyasu Hashida, et al.
Published: (2014-07-01)

The safety of interleukin-1 receptor antagonist (anakinra) in the treatment of rheumatoid arthritis
by: L. Riente
Published: (2011-09-01)

Exploring the Role of Interleukin-6 Receptor Inhibitor Tocilizumab in Patients with Active Rheumatoid Arthritis and Periodontal Disease
by: Codrina Ancuța, et al.
Published: (2021-02-01)

The relationship between rheumatoid-factor and anti-strptococcal peptidoglycan antibody in rheumatoid arthritis
by: Phua, K. K.
Published: (1985)

Inhibitor of biological effects of interleukin-6 sarilumab in treatment of rheumatoid arthritis
by: D. E. Karateev, et al.
Published: (2019-12-01)

Study of the effect of interleukin-6 gene polymorphism in patients with rheumatoid arthritis
by: Marwa H Sedira, et al.
Published: (2019-01-01)

NEW OPPORTUNITIES OF TREATMENT OF DIFFERENT TYPES OF JUVENILE ARTHRITIS WITH MONOCLONAL ANTIBODIES TO THE INTERLEUKIN 6 RECEPTOR
by: E.I. Alexeeva, et al.
Published: (2010-01-01)

NEW OPPORTUNITIES OF TREATMENT OF DIFFERENT TYPES OF JUVENILE ARTHRITIS WITH MONOCLONAL ANTIBODIES TO THE INTERLEUKIN 6 RECEPTOR
by: E.I. Alexeeva, et al.
Published: (2010-01-01)

INTERLEUKIN-6 (IL-6) LEVEL AS AN INDIKATOR OF PROGRESIVITY RHEUMATOID ARTHRITIS (RA) DISEASE
by: Putu Oky Ari Tania, et al.
Published: (2017-06-01)

Anti-mutated citrullinatedvimentin antibody for predicting the activity of rheumatoid arthritis
by: Kamal Esalatmanesh, et al.
Published: (2016-12-01)

The roles of anti-citrullinated protein antibodies in the immunopathogenesis of rheumatoid arthritis
by: Hui-Chun Yu, et al.
Published: (2019-01-01)

The Clinical Significance of Interleukin-1 Receptor Antagonist +2018 Polymorphism in Rheumatoid Arthritis.
by: Endom Ismail, et al.
Published: (2016-01-01)